SUTRO BIOPHARMA, INC. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Sutro Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q2 2024.
  • Sutro Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 81.9M shares, a 35.4% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 81.9M +21.4M +35.4% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 62.5M +2.29M +3.81% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 61M +3.51M +6.11% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 60.9M +6.27M +11.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 60.5M +11.8M +24.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 60.2M +13.2M +28.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 57.5M +11.2M +24.1% Dec 31, 2022 10-K 2024-03-25
Q3 2022 54.6M +8.37M +18.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 48.7M +2.53M +5.49% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 46.9M +823K +1.79% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 46.3M +575K +1.26% Dec 31, 2021 10-K 2023-03-30
Q3 2021 46.3M +8.17M +21.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 46.1M +10.3M +28.6% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 46.1M +22.9M +98.5% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 45.8M +22.7M +98.1% Dec 31, 2020 10-K 2022-02-28
Q3 2020 38.1M +15M +65% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 35.9M +13M +56.5% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 23.2M +302K +1.32% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 23.1M +251K +1.1% Dec 31, 2019 10-K 2021-03-18
Q3 2019 23.1M +22.6M +4660% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 22.9M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 22.9M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 22.8M +22.4M +4810% Dec 31, 2018 10-K 2020-03-16
Q3 2018 485K Sep 30, 2018 10-Q 2018-11-14
Q4 2017 465K Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.